Cargando…

Factors Influencing the Withdrawal of Antiepileptic Drugs in Adult Patients with Symptomatic Seizures Secondary to Neuronal Surface Antibodies-Associated Autoimmune Encephalitis

PURPOSE: This retrospective study aimed to investigate the relationship between clinical characteristics, seizure outcomes, and the potential factors influencing the withdrawal of antiepileptic drugs (AEDs) in adult patients with symptomatic seizures secondary to neuronal surface antibody (NSAb)-ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Fang, Wu, Yu, Nong, Weidong, Mao, Fengping, Cao, Xiaoli, Huang, Wen, Zheng, Jinou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842726/
https://www.ncbi.nlm.nih.gov/pubmed/35173460
http://dx.doi.org/10.2147/JIR.S347893
_version_ 1784651109470568448
author Huang, Fang
Wu, Yu
Nong, Weidong
Mao, Fengping
Cao, Xiaoli
Huang, Wen
Zheng, Jinou
author_facet Huang, Fang
Wu, Yu
Nong, Weidong
Mao, Fengping
Cao, Xiaoli
Huang, Wen
Zheng, Jinou
author_sort Huang, Fang
collection PubMed
description PURPOSE: This retrospective study aimed to investigate the relationship between clinical characteristics, seizure outcomes, and the potential factors influencing the withdrawal of antiepileptic drugs (AEDs) in adult patients with symptomatic seizures secondary to neuronal surface antibody (NSAb)-associated autoimmune encephalitis (AE). PATIENTS AND METHODS: Eighty-one patients (age ≥18 years) diagnosed with NSAb-associated AE were included in this retrospective study. After at least 1 year of follow-up, clinical details, magnetic resonance imaging (MRI) findings, electroencephalography (EEG) data, cerebrospinal fluid parameters, and the therapeutic outcomes were analyzed. Patients who needed long-term AEDs to control seizures were divided into two groups (withdrawal ≤1 year and withdrawal >1 year). Multivariable logistic regression analysis was performed to identify the risk factors affecting the AEDs’ withdrawal in patients with seizures secondary to NSAb-associated AE. RESULTS: During the 12-month follow-up after AEDs’ withdrawal, 28 (44.4%) patients among the 63 patients who needed long-term AEDs stopped AEDs within 1 year, while 35 (55.6%) patients continued AEDs treatment. Multivariable logistic regression analysis showed that delayed immunotherapy, status epilepticus (SE), and elevated intrathecal Immunoglobulin G synthesis rate of 24 hours (24-h intrathecal IgG) were independent risk factors for delayed withdrawal in patients with seizure secondary to NSAb-associated AE (odds ratios: 1.129, 6.497, 3.415, P<0.05). The receiver operating characteristics (ROC) curve analysis showed that the area under the curve (AUC) of delayed immunotherapy, SE, and elevated 24-h intrathecal IgG was 0.816 (95% CI=0.711–0.921, P<0.001). CONCLUSION: Delayed immunotherapy, status epilepticus and elevated 24-hour intrathecal IgG synthesis rate are the factors that may influence the decision to delay AEDs’ withdrawal.
format Online
Article
Text
id pubmed-8842726
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-88427262022-02-15 Factors Influencing the Withdrawal of Antiepileptic Drugs in Adult Patients with Symptomatic Seizures Secondary to Neuronal Surface Antibodies-Associated Autoimmune Encephalitis Huang, Fang Wu, Yu Nong, Weidong Mao, Fengping Cao, Xiaoli Huang, Wen Zheng, Jinou J Inflamm Res Original Research PURPOSE: This retrospective study aimed to investigate the relationship between clinical characteristics, seizure outcomes, and the potential factors influencing the withdrawal of antiepileptic drugs (AEDs) in adult patients with symptomatic seizures secondary to neuronal surface antibody (NSAb)-associated autoimmune encephalitis (AE). PATIENTS AND METHODS: Eighty-one patients (age ≥18 years) diagnosed with NSAb-associated AE were included in this retrospective study. After at least 1 year of follow-up, clinical details, magnetic resonance imaging (MRI) findings, electroencephalography (EEG) data, cerebrospinal fluid parameters, and the therapeutic outcomes were analyzed. Patients who needed long-term AEDs to control seizures were divided into two groups (withdrawal ≤1 year and withdrawal >1 year). Multivariable logistic regression analysis was performed to identify the risk factors affecting the AEDs’ withdrawal in patients with seizures secondary to NSAb-associated AE. RESULTS: During the 12-month follow-up after AEDs’ withdrawal, 28 (44.4%) patients among the 63 patients who needed long-term AEDs stopped AEDs within 1 year, while 35 (55.6%) patients continued AEDs treatment. Multivariable logistic regression analysis showed that delayed immunotherapy, status epilepticus (SE), and elevated intrathecal Immunoglobulin G synthesis rate of 24 hours (24-h intrathecal IgG) were independent risk factors for delayed withdrawal in patients with seizure secondary to NSAb-associated AE (odds ratios: 1.129, 6.497, 3.415, P<0.05). The receiver operating characteristics (ROC) curve analysis showed that the area under the curve (AUC) of delayed immunotherapy, SE, and elevated 24-h intrathecal IgG was 0.816 (95% CI=0.711–0.921, P<0.001). CONCLUSION: Delayed immunotherapy, status epilepticus and elevated 24-hour intrathecal IgG synthesis rate are the factors that may influence the decision to delay AEDs’ withdrawal. Dove 2022-02-09 /pmc/articles/PMC8842726/ /pubmed/35173460 http://dx.doi.org/10.2147/JIR.S347893 Text en © 2022 Huang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Huang, Fang
Wu, Yu
Nong, Weidong
Mao, Fengping
Cao, Xiaoli
Huang, Wen
Zheng, Jinou
Factors Influencing the Withdrawal of Antiepileptic Drugs in Adult Patients with Symptomatic Seizures Secondary to Neuronal Surface Antibodies-Associated Autoimmune Encephalitis
title Factors Influencing the Withdrawal of Antiepileptic Drugs in Adult Patients with Symptomatic Seizures Secondary to Neuronal Surface Antibodies-Associated Autoimmune Encephalitis
title_full Factors Influencing the Withdrawal of Antiepileptic Drugs in Adult Patients with Symptomatic Seizures Secondary to Neuronal Surface Antibodies-Associated Autoimmune Encephalitis
title_fullStr Factors Influencing the Withdrawal of Antiepileptic Drugs in Adult Patients with Symptomatic Seizures Secondary to Neuronal Surface Antibodies-Associated Autoimmune Encephalitis
title_full_unstemmed Factors Influencing the Withdrawal of Antiepileptic Drugs in Adult Patients with Symptomatic Seizures Secondary to Neuronal Surface Antibodies-Associated Autoimmune Encephalitis
title_short Factors Influencing the Withdrawal of Antiepileptic Drugs in Adult Patients with Symptomatic Seizures Secondary to Neuronal Surface Antibodies-Associated Autoimmune Encephalitis
title_sort factors influencing the withdrawal of antiepileptic drugs in adult patients with symptomatic seizures secondary to neuronal surface antibodies-associated autoimmune encephalitis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842726/
https://www.ncbi.nlm.nih.gov/pubmed/35173460
http://dx.doi.org/10.2147/JIR.S347893
work_keys_str_mv AT huangfang factorsinfluencingthewithdrawalofantiepilepticdrugsinadultpatientswithsymptomaticseizuressecondarytoneuronalsurfaceantibodiesassociatedautoimmuneencephalitis
AT wuyu factorsinfluencingthewithdrawalofantiepilepticdrugsinadultpatientswithsymptomaticseizuressecondarytoneuronalsurfaceantibodiesassociatedautoimmuneencephalitis
AT nongweidong factorsinfluencingthewithdrawalofantiepilepticdrugsinadultpatientswithsymptomaticseizuressecondarytoneuronalsurfaceantibodiesassociatedautoimmuneencephalitis
AT maofengping factorsinfluencingthewithdrawalofantiepilepticdrugsinadultpatientswithsymptomaticseizuressecondarytoneuronalsurfaceantibodiesassociatedautoimmuneencephalitis
AT caoxiaoli factorsinfluencingthewithdrawalofantiepilepticdrugsinadultpatientswithsymptomaticseizuressecondarytoneuronalsurfaceantibodiesassociatedautoimmuneencephalitis
AT huangwen factorsinfluencingthewithdrawalofantiepilepticdrugsinadultpatientswithsymptomaticseizuressecondarytoneuronalsurfaceantibodiesassociatedautoimmuneencephalitis
AT zhengjinou factorsinfluencingthewithdrawalofantiepilepticdrugsinadultpatientswithsymptomaticseizuressecondarytoneuronalsurfaceantibodiesassociatedautoimmuneencephalitis